Influence of hydroxyethyl starch on lipopolysaccharide-induced tissue nuclear factor kappa B activation and systemic TNF-α expression

Acta Anaesthesiologica Scandinavica

Volumn 49, Issue 9, 2005, Pages 1311-1317

  Tian, J ^a   Lin, X ^b   Li, Y H ^c   Xu, Jian Guo ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JINLING HOSPITAL   (China)

^c Department of Anesthesiology ^*  (China)

Author keywords

Hydroxyethyl starch; Lipopolysaccharide; NF B; TNF

Indexed keywords

HETASTARCH; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; LIVER; LOW DRUG DOSE; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOTRANSFORMATION; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HETASTARCH; LIPOPOLYSACCHARIDES; LIVER; LUNG; MALE; NF-KAPPA B; NUCLEAR PROTEINS; PLASMA SUBSTITUTES; PROTEIN BINDING; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 25444517084     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2005.00849.x     Document Type: Article

References (25)

1. Abraham E. NF-κB activation. Crit Care Med 2000; 28 [4 suppl.]: N100-4.
2. Paterson RL, Galley HF, Dhillon JK, Webster NR. Increased nuclear factor kappa B activation in critically ill patients who die. Crit Care Med 2000; 28: 1047-51.
3. Blackwell TS, Blackwell TR, Christman JW. Impaired activation of nuclear factor-kappaB in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation. J Immunol 1997; 158: 5934-40.
4. Shenkar R, Schwarte MD, Terada LS, Repine JE, McCord J, Abraham E. Hemorrhage activates NF-kappa B in murine lung mononuclear cells in vivo. Am J Physiol 1996; 270: L729-35.
5. Bohrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Mannel D et al. Role of NFkappaB in the mortality of sepsis. J Clin Invest 1997; 100: 972-85.
6. Yeh T Jr, Parmar JM, Rebeyka IM, Lofland GK, Allen EL, Dignan RJ et al. Limiting edema in neonatal cardiopulmonary bypass with narrow-range molecular weight hydroxyethyl starch. J Thorac Cardiovasc Surg 1992; 104: 659-65.
7. Webb AR, Moss RF, Tighe D, Mythen MG, al-Saady N, Joseph AE et al. A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis. Intensive Care Med 1992; 18: 348-55.
8. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145: 1016-22.
9. Bohlinger I, Leist M, Gantner F, Angermuller S, Tiegs G, Wendel A. DNA fragmentation in mouse organs during endotoxic shock. Am J Pathol 1996; 149: 1381-93.
10. Jaeschke H. Mechanisms of oxidant stress-induced acute tissue injury. Proc Soc Exp Biol Med 1995; 209: 104-11.
11. Liu SF, Ye X, Malik AB. Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol 1999; 55: 658-67.
12. Tian J, Lin X, Guan R, Xu JG. The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesth Analg 2004; 98: 768-74.
13. Armistead CW Jr, Vincent JL, Preiser JC, De Backer D, Thuc Le Minh. Hypertonic saline solution-hetastarch for fluid resuscitation in experimental septic shock. Anesth Analg 1989; 69: 714-20.
14. Mehlhorn U, Allen SJ, Davis KL, Geissler HJ, Warters RD, Rainer de Vivie E. Increasing the colloid osmotic pressure of cardiopulmonary bypass prime and normothermic blood cardioplegia minimizes myocardial oedema and prevents cardiac dysfunction. Cardiovasc Surg 1998; 6: 274-81.
15. Zikria BA, Subbarao C, Oz MC, Popilkis SJ, Sachdev R, Chauhan P et al. Hydroxyethyl starch macromolecules reduce myocardial reperfusion injury. Arch Surg 1990; 125: 930-4.
16. Bauer C, Walcher F, Holanda M, Mertzlufft F, Larsen R, Marzi I. Antioxidative resuscitation solution prevents leukocyte adhesion in the liver after hemorrhagic shock. J Trauma 1999; 46: 886-93.
17. Tian J, Lin X, Zhou W, Xu JG. Hydroxyethyl starch inhibits NF-kappaB activation and prevents the expression of inflammatory mediators in endotoxic rats. Ann Clin Lab Sci 2003; 33: 451-8.
18. Baumgarten G, Knuefermann P, Nozaki N, Sivasubramanian N, Mann DL, Vallejo JG. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis 2001; 183: 1617-24.
19. Szabo G, Romics L Jr, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 2002; 6: 1045-66.
20. Di Giantomasso D, Morimatsu H, May CN, Bellomo R. Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine. Crit Care Med 2003; 31: 2509-13.
21. Morrissey JJ, Klahr S. Transcription factor NF-κB regulation of renal fibrosis during ureteral obstruction. Semin Nephrol 1998; 18: 603-11.
22. Zhang F, Siow YL, O K. Hyperhomocysteinemia activates NF-kappaB and inducible nitric oxide synthase in the kidney. Kidney Int 2004; 65: 1327-38.
23. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-2.
24. Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis. Nephrol Dial Transplant 1999; 14: 1517-20.
25. Boldt J, Muller M, Mentges D, Papsdorf M, Hempelmann G. Volume therapy in the critically ill: is there a difference? Intensive Care Med 1998; 24: 28-36.